10
Participants
Start Date
January 11, 2019
Primary Completion Date
March 28, 2022
Study Completion Date
March 28, 2022
Letermovir
"Patients will receive intravenous or oral letermovir at a dose of 480mg/day.~Patients weighing 40 or more kilograms will receive a second, loading, dose 12 hours after the first dose of letermovir treatment.~For patients receiving concomitant cyclosporine treatment, the letermovir dose will be 240mg/day."
Brigham and Women's Hospital, Boston
Massachusetts General Hospital Cancer Center, Boston
Boston Children's Hospital, Boston
Dana-Farber Cancer Institute, Boston
Merck Sharp & Dohme LLC
INDUSTRY
Amy C. Sherman, MD
OTHER